Atherosclerosis
Volume 213, Issue 1 , Pages 59-66 , November 2010

AAV/hSTAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol

  • Junaid A. Khan

      Affiliations

    • Central Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA
    • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    • ,
  • Maohua Cao

      Affiliations

    • Central Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA
    • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    • ,
  • Bum-Yong Kang

      Affiliations

    • Central Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA
    • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    • Department of Medicine, Atlanta Veterans Affairs and Emory University Medical Centers, Atlanta, Georgia
    • ,
  • Yong Liu

      Affiliations

    • Central Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA
    • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    • ,
  • Jawahar L. Mehta

      Affiliations

    • Central Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA
    • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    • ,
  • Paul L. Hermonat

      Affiliations

    • Central Arkansas Veterans Healthcare System, 111J, 4300 West 7th Street, Little Rock, AR 72205, USA
    • Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    • Corresponding Author InformationCorresponding author at: Division of Cardiology, Slot 532, University of Arkansas for Medical Sciences and VA Medical Center, Little Rock, AR 72205, USA. Tel.: +1 501 526 4606; fax: +1 501 686 7873.

Received 21 November 2009 ,Revised 19 July 2010 ,Accepted 20 July 2010.

References 

  1. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168–175
  3. Sela S, Shurtz-Swirski R, Awad J, et al. The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers. Israel Med Ass J. 2002;4:1015–1019
  4. Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation. Thromb Haemost. 1999;82:695–705
  5. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 1996;94:3090–3097
  6. Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther. 2002;300:729–735
  7. Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Thromb Vasc Biol. 2003;23:17–25
  8. Matthay MA. Severe sepsis – a new treatment with both anticoagulant and antiinflamatory properties. N Engl J Med. 2001;344:759–762
  9. Liu Y, Li D, Chen J, et al. Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis. 2006;188:19–27
  10. Chen S, Kapturczak MH, Wasserfall C, et al. Agarwal A. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci USA. 2005;102(20):7251–7256
  11. Yoshioka T, Okada T, Maeda Y, et al. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Gene Ther. 2004;11:1772–1779
  12. Williams LM, Sarma U, Willets K, Smallie T, Brennan F, Foxwell BM. Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages. J Biol Chem. 2007;282(10):6965–6975
  13. El Kasmi KC, Holst J, Coffre M, et al. General nature of the STAT3-activated anti-inflammatory response. J Immunol. 2006;177:7880–7888
  14. Nishinakamura H, Minoda Y, Saeki K, et al. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity. Int Immunol. 2007;19(5):609–619
  15. Kotenko SV, Pestka S. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene. 2000;19(21):2557–2565
  16. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol. 2002;169(5):2253–2263
  17. Hermonat PL, Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA. 1984;81:6466–6470
  18. You CX, Liu Y, Shi M, Cao M, Luo R-C, Hermonat PL. Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function. Cancer Immun Immunother. 2010;2010:270985
  19. Hu C, Dandapat A, Chen J, et al. Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis. 2008;199(2):288–294
  20. Martin-McNulty B, Vincelette J, Vergona R, Sullivan ME, Wang YX. Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system. Ultrasound Med Biol. 2005;31(6):745–749
  21. Kang BY, Hu C, Prayaga S, et al. LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II. Biochem Biophys Res Commun. 2009;379(2):395–399
  22. Li D, Liu Y, Chen J, et al. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice. Biochem Biophys Res Commun. 2006;344(3):701–707
  23. Yaozhong D, Dongmei C, Tracsafalvi A, Su R, Lihui Q, Bromberg JS. Suppressor of cytokine signaling inhibits IL-10-mediated immune responses. J Immun. 2003;170:1383–1391
  24. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. Methods Mol Biol. 2003;209:293–309
  25. Chen J, Tung CH, Mahmood U, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105:2766–2771
  26. Beckmann JS, Ye YZ, Anderson PG, et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994;375:81–88
  27. Grothusen C, Schuett H, Lumpe S, et al. Suppression of macrophage recruitment, foam cell formation and atheropgenesis by the negative regulator of cytokine signaling SOCS1. Circulation. 2009;120:S1044
  28. Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T lymphocytes on atherosclerosis. Arterio Thromb Vascul Biol. 2007;27:2493
  29. Katoh M, Katoh M. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer. Int J Mol Med. 2007;19(2):273–278
  30. Simeone-Penney MC, Severgnini M, Tu P, et al. Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma. J Immunol. 2007;178(10):6191–6199
  31. Leeman RJ, Liu VW, Grandis JR. STAT3 as a therapeutic target in head and neck cancer. Expert Opin Biol Ther. 2006;6:231–241
  32. Mulder CJ, Wahab PJ, Meijer JW, Metselaar E. A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol. 2001;13(10):1183–1188
  33. Richter M, Iwata A, Nyhuis J, et al. Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genomics. 2000;2:17–127

PII: S0021-9150(10)00574-5

doi: 10.1016/j.atherosclerosis.2010.07.029

Atherosclerosis
Volume 213, Issue 1 , Pages 59-66 , November 2010

Article Tools

* Image Usage & Resolution